INFECTION, THROMBOSIS, EMBOLISM & BLEEDING WORKING GROUP

The Working Group has constituted a board which is elected by the working group members every two years. Presently, the chairman of the Working Group is Dieter Horstkotte, MD, FESC, FACCP. The co-chairman is Maria Lengyel, MD, FESC, FACC. The secretary is Wilhelm Mistiaen, MD and the treasurer Heinz Völler, MD.

There is a scientific office of the Working Group which is located at the site of the chairperson.

During the recent years, we had the following activities:
(a) Postgraduate course: Modern aspects of antithrombotic treatment. Paris, June 2003

(b) Point of care symposium in Berlin, September 2006
     The results of the Berlin meeting have been published in the Journal of Heart
      Valve Disease.

(c) There is a formal cooperation between the Working Group and the ISMAA
     (International Self-monitoring Association for oral Anticoagulation).

(d) Since 2005, the following business meetings of our Working Group were
      held
      - Paris 2003 (constitutional session)
      - Düsseldorf 2004
      - Paris, January 2005
      - Frankfurt, June 2005
      - Stockholm, September 2005
      - Brussels, April 2007
      - Vienna, September 2007

(e) On behalf of the Working Group, the following publications were made
       - Horstkotte D et al. Recommendations for reporting morbid events after heart valve

         surgery. J Heart Valve Dis 2005;14:1-7
       - Lengyel M. et al. Recommendations for the management of prosthetic valve

         thrombosis. J Heart Valve Dis 2005;14:567-575
       - Horstkotte D et al. Recommendations for post-discharge patient follow-up after

         cardiac valve interventions: A Position Paper. J Heart Valve Dis 2007; 16:575-589

(f) Officials of our Working Group have published the following editorials
     - Horstkotte D et al. Discontinuing oral anticoagulation therapy.

       J Heart Valve Dis. 2007;16:282-4
     - Horstkotte D et al. Management of active infective endocarditis complicated by large
       vegetations. J Heart Valve Dis 2006;15:563-6
     - Horstkotte D et al. Cardiac resynchronization therapy as an alternative to valve
       replacement in high-risk patients with a chronically decompensated aortic stenosis?
        J Heart Valve Dis 2005;15:203-5

The Board of the Working Group will discuss the proposals of the executive committee during the next meeting and will support the ideas appropriately.

 

 

Dieter Horstkotte, MD, FESC, FACCP 

 

 Updated: 14 May 2009